Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 12, 2026
High vulnerability of medial prefrontal pyramidal neurons in post-stroke, vascular, Alzheimer's disease, and aging-related dementiasDan D Jobson, Yoshiki Hase, Lauren Walker, et al.
Translational Stroke Research|May 31, 2022
Transcriptomic Profiling Reveals Discrete Poststroke Dementia Neuronal and Gliovascular SignaturesRachel Waller, Yoshiki Hase, Julie E Simpson, et al.
Brain Pathology (Zurich, Switzerland)|January 11, 2019
Brain-derived and circulating vesicle profiles indicate neurovascular unit dysfunction in early Alzheimer's diseaseXavier Gallart-Palau, Aida Serra, Yoshiki Hase, et al.
Experimental Neurology|December 17, 2011
Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemiaYoshiki Hase, Yoko Okamoto, Youshi Fujita, et al.
Plos One|October 25, 2012
In vivo imaging of brain ischemia using an oxygen-dependent degradative fusion protein probeYoushi Fujita, Takahiro Kuchimaru, Tetsuya Kadonosono, et al.
Acta Neuropathologica Communications|February 9, 2019
White matter capillaries in vascular and neurodegenerative dementiasYoshiki Hase, Ren Ding, Gina Harrison, et al.
Acta Neuropathologica Communications|February 15, 2024
Hippocampal capillary pericytes in post-stroke and vascular dementias and Alzheimer's disease and experimental chronic cerebral hypoperfusionYoshiki Hase, Dan Jobson, Jeremy Cheong, et al.
Brain Pathology (Zurich, Switzerland)|May 15, 2018
Severe white matter astrocytopathy in CADASILYoshiki Hase, Aiqing Chen, Letitia L Bates, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 10, 2017
The effects of environmental enrichment on white matter pathology in a mouse model of chronic cerebral hypoperfusionYoshiki Hase, Lucinda Craggs, Mai Hase, et al.
Pageof 4